Fulcrum Therapeutics's total assets for Q3 2025 were $214.86M, a decrease of -6.11% from the previous quarter. FULC total liabilities were $16.49M for the fiscal quarter, a 14.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.